Latest filing published 19 Feb 2026 for Idexx Laboratories INC /de, €266k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Sophie Vandebroek V is a declared insider at 2 companies (board member); the most frequent names are Idexx Laboratories INC /de and Revvity, Inc. The record holds 12 filings, for trades running from 11 May 2022 to 17 February 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 19 February 2026 came the latest disclosure, an option exercise for €266k in Idexx Laboratories INC /de. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations